Cite
HARVARD Citation
Frega, S. et al. (2016). A Triple Rare E709K and L833V/H835LEGFRMutation Responsive to an Irreversible Pan‐HER Inhibitor: A Case Report of Lung Adenocarcinoma Treated with Afatinib. Journal of thoracic oncology. 11 (5), p. . [Online].